(September 11, 2020) Ultra-Cheap, Sensitive DNA Nanoswitch Tech Developed for SARS-CoV-2 Detection
(September 10th, 2020) COVID-19 Pooled Surveillance Testing is Underway.
(September 8th, 2020) Saliva Test for COVID-19: Researchers Enable Alternative to Nasal Swabs
(September 4, 2020) The Scientist’s Channel interviews Dr. Igor Lednev.
(September 4, 2020) A platform for low-cost and rapid detection of viral RNA
(September 3, 2020) UAlbany Spearheads Pooled Saliva Testing on Students and Staff
(September 1, 2020) Chancellor Malatras Visits Campus to Unveil Pooled Surveillance Testing
(August 26, 2020) UAlbany’s COVID-19 pooled testing will monitor thousands on campus
(August 24, 2020) New drool-based tests are replacing the dreaded coronavirus nasal swab
(August 14, 2020) Dr. Andy Berglund and 3 Summer Fellows sit down with Paul Grondahl from the NYS Writers Institute for The Conversation.
(May 27th, 2020) – Dr. Alan Chen Published in Nature
April 29, 2020
By Melissa Fassbender
AMRI and The RNA Institute at UAlbany have entered into a collaboration to advance the discovery and development of RNA-based therapeutics and research tools.
AMRI, which works in drug contract research, development and manufacturing, will use tools and quality assessment standards from the institute for its clients’
“RNA holds great promise for designing drugs that treat numerous diseases, such as breast cancer, Alzheimer’s disease, and HIV…”
“The RNA Institute at the University at Albany is settling into its niche as a technology development center…”
“Poor RNA. It has never managed to attract the scientific spotlight that DNA has…”
“As researchers across the country try to come up with treatment and drugs for things like Cancer, HIV and Ebola, scientists at the University at Albany…”
The RNA Institute of University at Albany has received a gift, valued at $400,000, that will greatly enhance its ribonucleic acid-based research capabilities.